Form 3 Filing for Achieve Life Sciences, Inc. Director Christopher Martin

2026-05-13SEC Filing 3 (0001193125-26-221733)

This filing is a Form 3, which reports initial beneficial ownership of securities. It indicates that Christopher Martin, a director of Achieve Life Sciences, Inc., has no securities beneficially owned following the reporting period. The filing also includes a Limited Power of Attorney document, appointing Sandra Thomson as attorney-in-fact to execute and file necessary SEC forms (Forms 3, 4, and 5) on behalf of Mr. Martin. This power of attorney authorizes Ms. Thomson to act on Mr. Martin's behalf regarding his reporting obligations under Section 16 of the Securities Exchange Act of 1934. The document specifies that this power of attorney supersedes any previous ones and remains in effect until Mr. Martin is no longer required to file such forms or until it is revoked or superseded.

Ticker mentioned:ACHV